EP2481405
Nanóagnir úr paklítaxeli og albúmíni í samsetningu með bevacízúmabi gegn krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.11.2007EP published:
23.3.2016EP application number:
12154995.0
EP translation filed:
7.6.2016Grant published:
15.7.2016EPO information:
European Patent Register
Max expiry date:
5.11.2027Expiry date:
5.11.2026Next due date:
30.11.2026
Title:
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
Timeline
Today
6.11.2007EP application
23.3.2016EP Publication
7.6.2016Translation submitted
15.7.2016Registration published
5.11.2026Expires
Owner
Name:
Abraxis BioScience, LLCAddress:
86 Morris Avenue, 07901, Summit, NJ, US
Inventor
Name:
Desai, Neil P.Address:
Los Angeles, CA, US
Name:
Soon-Shiong, PatrickAddress:
Los Angeles, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
594417Date:
6.11.2006Country:
US
Classification
Categories:
A61K 31/337, A61K 39/395, A61K 45/06, A61P 35/04, A61P 35/00, A61K 31/282, A61K 33/24, A61K 31/7072, A61K 9/00, A61K 9/51
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 18.10.2016
Expires: 5.11.2017
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.10.2017
Expires: 5.11.2018
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.10.2018
Expires: 5.11.2019
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 18.10.2019
Expires: 5.11.2020
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 6.10.2020
Expires: 5.11.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.10.2021
Expires: 5.11.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 6.10.2022
Expires: 5.11.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.11.2023
Expires: 5.11.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 8.10.2024
Expires: 5.11.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 4.11.2025
Expires: 5.11.2026
Payer: Árnason Faktor ehf.